Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology
N.A. Mark Estes III, Richard J. Kovacs, Aaron L. Baggish, Robert J. Myerburg, and on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology
Circulation. 2015; published online before print November 2 2015, doi:10.1161/CIR.0000000000000247
The American Heart Association and American College of Cardiology have released a series of scientific statements regarding eligibility and disqualification recommendation for competitive athletes with cardiovascular abnormalities. This is the 12th document of 15 scientific statements. This document discusses the athletic participation and drugs and performance-enhancing substances. The document includes 5 recommendations at the end of the document.
View 89 other recent position statements, consensus statements, guidelines, and recommendations related to sports medicine.